1. Home
  2. SPRB vs MOVE Comparison

SPRB vs MOVE Comparison

Compare SPRB & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • MOVE
  • Stock Information
  • Founded
  • SPRB 2014
  • MOVE 2018
  • Country
  • SPRB United States
  • MOVE United States
  • Employees
  • SPRB N/A
  • MOVE N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SPRB Health Care
  • MOVE Health Care
  • Exchange
  • SPRB Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • SPRB 22.8M
  • MOVE 25.9M
  • IPO Year
  • SPRB 2020
  • MOVE 2021
  • Fundamental
  • Price
  • SPRB $0.38
  • MOVE $5.98
  • Analyst Decision
  • SPRB Hold
  • MOVE Buy
  • Analyst Count
  • SPRB 7
  • MOVE 1
  • Target Price
  • SPRB $2.17
  • MOVE $30.00
  • AVG Volume (30 Days)
  • SPRB 870.1K
  • MOVE 84.2K
  • Earning Date
  • SPRB 11-11-2024
  • MOVE 11-14-2024
  • Dividend Yield
  • SPRB N/A
  • MOVE N/A
  • EPS Growth
  • SPRB N/A
  • MOVE N/A
  • EPS
  • SPRB N/A
  • MOVE N/A
  • Revenue
  • SPRB $7,101,000.00
  • MOVE $902,000.00
  • Revenue This Year
  • SPRB N/A
  • MOVE N/A
  • Revenue Next Year
  • SPRB N/A
  • MOVE $545.31
  • P/E Ratio
  • SPRB N/A
  • MOVE N/A
  • Revenue Growth
  • SPRB N/A
  • MOVE N/A
  • 52 Week Low
  • SPRB $0.37
  • MOVE $2.80
  • 52 Week High
  • SPRB $5.95
  • MOVE $12.75
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 31.70
  • MOVE 60.59
  • Support Level
  • SPRB $0.37
  • MOVE $5.75
  • Resistance Level
  • SPRB $0.42
  • MOVE $6.97
  • Average True Range (ATR)
  • SPRB 0.04
  • MOVE 0.52
  • MACD
  • SPRB -0.01
  • MOVE 0.05
  • Stochastic Oscillator
  • SPRB 5.93
  • MOVE 54.36

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: